Followers | 251 |
Posts | 50180 |
Boards Moderated | 47 |
Alias Born | 08/29/2007 |
Saturday, January 20, 2024 9:25:41 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ORIC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:20:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:10:15 PM
- ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:30:00 PM
- ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC • GlobeNewswire Inc. • 04/15/2024 08:15:00 PM
- ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/05/2024 08:30:00 PM
- ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/04/2024 08:30:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/11/2024 09:28:33 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:20:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:10:11 PM
- ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/06/2024 09:30:00 PM
- ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/01/2024 09:30:00 PM
- ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit • GlobeNewswire Inc. • 02/14/2024 09:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/05/2024 05:15:31 AM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2024 09:30:00 PM
- ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/31/2024 09:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/26/2024 09:58:24 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/25/2024 06:24:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 02:01:29 PM
- ORIC Pharmaceuticals Announces $125 Million Private Placement Financing • GlobeNewswire Inc. • 01/22/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 02:00:42 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM